G1-4A, a Polysaccharide from Tinospora cordifolia Inhibits the Survival of Mycobacterium tuberculosis by Modulating Host Immune Responses in TLR4 Dependent Manner

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Gupta, Pramod Kumar ^a   Chakraborty, Pampi ^a   Kumar, Santosh ^b,c   Singh, Prafull Kumar ^b,d   Rajan, M G R ^a   Sainis, Krishna B ^a   Kulkarni, Savita ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

POLYSACCHARIDE; TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4;

ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; INNATE IMMUNITY; ISOLATION AND PURIFICATION; MACROPHAGE; MICROBIOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTOSIS; PHYSIOLOGY; TINOSPORA;

ANIMALS; CELL LINE; IMMUNITY, INNATE; MACROPHAGES; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTOSIS; POLYSACCHARIDES; TINOSPORA; TOLL-LIKE RECEPTOR 4;

EID: 84983418907     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154725     Document Type: Article

References (46)

1. Hestvik AL, Hmama Z, Av-Gay Y. Mycobacterial manipulation of the host cell. FEMS microbiology reviews. 2005; 29(5):1041–50. doi: 10.1016/j.femsre.2005.04.013 PMID: 16040149.
2. Clemens DL, Horwitz MA. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited. The Journal of experimental medicine. 1995; 181 (1):257–70. PMID: 7807006; PubMed Central PMCID: PMC2191842.
3. Armstrong JA, Hart PD. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. The Journal of experimental medicine. 1975; 142(1):1–16. PMID: 807671; PubMed Central PMCID: PMC2189870.
4. Moreno C, Mehlert A, Lamb J. The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clinical and experimental immunology. 1988; 74(2):206–10. PMID: 3147152; PubMed Central PMCID: PMC1541790.
5. Sibley LD, Hunter SW, Brennan PJ, Krahenbuhl JL. Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infection and immunity. 1988; 56(5):1232–6. PMID: 3128482; PubMed Central PMCID: PMC259795.
6. Chan J, Fan XD, Hunter SW, Brennan PJ, Bloom BR. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infection and immunity. 1991; 59(5):1755–61. PMID: 1850379; PubMed Central PMCID: PMC257912.
7. Keane J, Remold HG, Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. Journal of immunology. 2000; 164(4):2016–20. PMID: 10657653.
8. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha. Journal of immunology. 1998; 161(5):2636–41. PMID: 9725266.
9. Kobayashi SD, Braughton KR, Whitney AR, Voyich JM, Schwan TG, Musser JM, et al. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100(19):10948–53. doi: 10.1073/pnas. 1833375100 PMID: 12960399; PubMed Central PMCID: PMC196908.
10. Redford PS, Murray PJ, O'Garra A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal immunology. 2011; 4(3):261–70. doi: 10.1038/mi.2011.7 PMID: 21451501.
11. Koul A, Herget T, Klebl B, Ullrich A. Interplay between mycobacteria and host signalling pathways. Nature reviews Microbiology. 2004; 2(3):189–202. doi: 10.1038/nrmicro840 PMID: 15083155.
12. Hancock RE, Nijnik A, Philpott DJ. Modulating immunity as a therapy for bacterial infections. Nature reviews Microbiology. 2012; 10(4):243–54. doi: 10.1038/nrmicro2745 PMID: 22421877.
13. Ulevitch RJ. Therapeutics targeting the innate immune system. Nature reviews Immunology. 2004; 4 (7):512–20. doi: 10.1038/nri1396 PMID: 15229470.
14. Hamill P, Brown K, Jenssen H, Hancock RE. Novel anti-infectives: is host defence the answer? Current opinion in biotechnology. 2008; 19(6):628–36. doi: 10.1016/j.copbio.2008.10.006 PMID: 19000763.
15. Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nature medicine. 2007; 13(5):552–9. doi: 10.1038/nm1589 PMID: 17479101.
16. Finlay BB, Hancock RE. Can innate immunity be enhanced to treat microbial infections? Nature reviews Microbiology. 2004; 2(6):497–504. doi: 10.1038/nrmicro908 PMID: 15152205.
17. Thatte UM, Kulkarni MR, Dahanukar SA. Immunotherapeutic modification of Escherichia coli peritonitis and bacteremia by Tinospora cordifolia. Journal of postgraduate medicine. 1992; 38(1):13–5. PMID: 1512717.
18. Raghu R, Sharma D, Ramakrishnan R, Khanam S, Chintalwar GJ, Sainis KB. Molecular events in the activation of B cells and macrophages by a non-microbial TLR4 agonist, G1-4A from Tinospora cordifolia. Immunology letters. 2009; 123(1):60–71. doi: 10.1016/j.imlet.2009.02.005 PMID: 19428553.
19. Desai VR, Ramkrishnan R, Chintalwar GJ, Sainis KB. G1-4A, an immunomodulatory polysaccharide from Tinospora cordifolia, modulates macrophage responses and protects mice against lipopolysaccharide induced endotoxic shock. International immunopharmacology. 2007; 7(10):1375–86. doi: 10. 1016/j.intimp.2007.06.004 PMID: 17673153.
20. Chintalwar G, Jain A, Sipahimalani A, Banerji A, Sumariwalla P, Ramakrishnan R, et al. An immunologically active arabinogalactan from Tinospora cordifolia. Phytochemistry. 1999; 52(6):1089–93. PMID: 10643671.
21. Pandey VK, Shankar BS, Sainis KB. G1-4 A, an arabinogalactan polysaccharide from Tinospora cordifolia increases dendritic cell immunogenicity in a murine lymphoma model. International immunopharmacology. 2012; 14(4):641–9. doi: 10.1016/j.intimp.2012.09.020 PMID: 23079132.
22. Chakraborty P, Kulkarni S, Rajan R, Sainis K. Drug resistant clinical isolates of Mycobacterium tuberculosis from different genotypes exhibit differential host responses in THP-1 cells. PloS one. 2013; 8(5): e62966. doi: 10.1371/journal.pone.0062966 PMID: 23667550; PubMed Central PMCID: PMC3646887.
23. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. Journal of immunology. 1988; 141(7):2407–12. PMID: 3139757.
24. Dey R, Majumder N, Bhattacharyya Majumdar S, Bhattacharjee S, Banerjee S, Roy S, et al. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice. Scandinavian journal of immunology. 2007; 66(6):671–83. doi: 10.1111/j.1365-3083.2007. 02025.x PMID: 18021365.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402–8. doi: 10.1006/meth.2001.1262 PMID: 11846609.
26. Zhao T, Feng Y, Li J, Mao R, Zou Y, Feng W, et al. Schisandra polysaccharide evokes immunomodulatory activity through TLR 4-mediated activation of macrophages. International journal of biological macromolecules. 2014; 65:33–40. doi: 10.1016/j.ijbiomac.2014.01.018 PMID: 24418335.
27. Yoon YD, Han SB, Kang JS, Lee CW, Park SK, Lee HS, et al. Toll-like receptor 4-dependent activation of macrophages by polysaccharide isolated from the radix of Platycodon grandiflorum. International immunopharmacology. 2003; 3(13–14):1873–82. doi: 10.1016/j.intimp.2003.09.005 PMID: 14636836.
28. Chen S, Yin DK, Yao WB, Wang YD, Zhang YR, Gao XD. Macrophage receptors of polysaccharide isolated from a marine filamentous fungus Phoma herbarum YS4108. Acta pharmacologica Sinica. 2009; 30(7):1008–14. doi: 10.1038/aps.2009.93 PMID: 19575004; PubMed Central PMCID: PMC4006659.
29. Mosser DM. The many faces of macrophage activation. Journal of leukocyte biology. 2003; 73(2):209–12. PMID: 12554797.
30. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. Journal of immunology. 2008; 181(6):3733–9. PMID: 18768823.
31. Kahnert A, Seiler P, Stein M, Bandermann S, Hahnke K, Mollenkopf H, et al. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. European journal of immunology. 2006; 36(3):631–47. doi: 10.1002/eji.200535496 PMID: 16479545.
32. Lugo-Villarino G, Verollet C, Maridonneau-Parini I, Neyrolles O. Macrophage polarization: convergence point targeted by mycobacterium tuberculosis and HIV. Frontiers in immunology. 2011; 2:43. doi: 10. 3389/fimmu.2011.00043 PMID: 22566833; PubMed Central PMCID: PMC3342390.
33. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. Journal of immunology. 1991; 147(11):3815–22. PMID: 1940369.
34. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. Journal of immunology. 1991; 146(10):3444–51. PMID: 1827484.
35. Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. Journal of immunology. 1992; 148(6):1792–6. PMID: 1541819.
36. Redpath S, Ghazal P, Gascoigne NR. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends in microbiology. 2001; 9(2):86–92. PMID: 11173248.
37. Hornef MW, Wick MJ, Rhen M, Normark S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nature immunology. 2002; 3(11):1033–40. doi: 10.1038/ni1102-1033 PMID: 12407412.
38. Redford PS, Boonstra A, Read S, Pitt J, Graham C, Stavropoulos E, et al. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. European journal of immunology. 2010; 40(8):2200–10. doi: 10.1002/eji. 201040433 PMID: 20518032; PubMed Central PMCID: PMC3378704.
39. Herbst S, Schaible UE, Schneider BE. Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PloS one. 2011; 6(5):e19105. doi: 10.1371/journal.pone.0019105 PMID: 21559306; PubMed Central PMCID: PMC3085516.
40. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science. 2001; 291(5508):1544–7. doi: 10. 1126/science.291.5508.1544 PMID: 11222859.
41. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000; 406(6797):782–7. doi: 10.1038/35021228 PMID: 10963608.
42. Imler JL, Hoffmann JA. Toll receptors in innate immunity. Trends in cell biology. 2001; 11(7):304–11. PMID: 11413042.
43. Ando I, Tsukumo Y, Wakabayashi T, Akashi S, Miyake K, Kataoka T, et al. Safflower polysaccharides activate the transcription factor NF-kappa B via Toll-like receptor 4 and induce cytokine production by macrophages. International immunopharmacology. 2002; 2(8):1155–62. PMID: 12349952.
44. van Crevel R, Karyadi E, Preyers F, Leenders M, Kullberg BJ, Nelwan RH, et al. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. The Journal of infectious diseases. 2000; 181(3):1194–7. doi: 10.1086/315325 PMID: 10720554.
45. Flynn JL, Chan J. Immunology of tuberculosis. Annual review of immunology. 2001; 19:93–129. doi: 10.1146/annurev.immunol.19.1.93 PMID: 11244032.
46. Dwivedi VP, Bhattacharya D, Chatterjee S, Prasad DV, Chattopadhyay D, Van Kaer L, et al. Mycobacterium tuberculosis directs T helper 2 cell differentiation by inducing interleukin-1beta production in dendritic cells. The Journal of biological chemistry. 2012; 287(40):33656–63. doi: 10.1074/jbc.M112. 375154 PMID: 22810226; PubMed Central PMCID: PMC3460463.